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SUMMARY 
1. To investigate the role of the Jun transcnpt1on factors in neuronal 
differentiation, programmed neuronal cell death, and neuronal plasticity, we used 
phosphorothioate oligodeoxynucleotides (S-ODN) to inhibit selectively the ex-
pression of c-Jun, JunB, and JunD. 
2. We have shown previously that in contrast to c-Jun, the JunB and JunD 
transcription factors are negative regulators of cell growth in various cell lines. 
Here we confirm this finding in primary human fibroblasts. 
3. c-Jun and JunB are counterplayers not only with respect to proliferation, 
but also in cell differentiation. Since JunB expression is essential for neuronal 
differentiation, we analyzed possible posttranslational modifications of JunB after 
induction of PC-12 cell differentiation by nerve growth factor (NGF). 
4. J unB was strongly phosphorylated after induction of PC-12 cell 
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differentiation with NGF but not after stimulation of cell proliferation with 
serum. Thus, while cell proliferation is associated with c-Jun phosphorylation, cell 
differentiation is correlated with JunB phosphorylation. This supports the finding 
that c-Jun and JunB play antagonistic roles in both proliferation and 
differentiation. 
5. The JunB transcription factor together with the c-Fos transcription factor 
is also induced in vivo in the suprachiasmatic nucleus (SCN) of rat brain after a 
light stimulus that induces resetting of the circadian clock. 
6. Using antisense oligonucleotides injected into the third ventricle, we 
selectively cosuppressed the two transcription factors in vivo as shown by 
immunohistochemistry. Expression of c-Jun, JunD, and FosB was not affected. 
Inhibition of JunB and c-Fos expression prevented the light-induced phase shift of 
the circadian rhythm. In contrast, rats injected with a randomized control 
oligonucleotide showed the same phase shift as untreated animals. 
7. In primary rat hippocampal cultures, anti-c-jun S-ODN selectively inhib-
ited neuronal cell death and promoted neuronal survival. This indicates a causal 
role of c-Jun in programmed neuronal cell death. 
8. These findings demonstrate the essential role of inducible transcription 
factors in the reprogramming of cells to a different functional state. Jun 
transcription factors play an essential role not only in fundamental processes such 
as cell proliferation, differentiation, and programmed neuronal cell death, but 
also in such complex processes as plastic adaptations in the mature brain. The 
inhibition of neuronal cell death by anti-c-jun S-ODN shows the great therapeutic 
potential of selective antisense oligonucleotides. 
INTRODUCTION 
How do cells alter their genetic program to allow long-term changes in 
function and structure? Which genes reprogram the cell to induce, e.g., 
proliferation after quiescence or to initiate differentiation of proliferating cells? 
Do such regulatory genes also play a role in programmed neuronal cell death and 
in neuronal plasticity? Inducible transcription factors such as members of the Jun 
protein family are prime candidates to orchestrate these changes at the level of 
gene expression. 
Reprogramming of cell function and structure requires the coordinated 
induction of previously silent genes and the repression of certain currently active 
genes. Rapid induction and/ or posttranslational modification of transcription 
factors can be hypothesized to play an essential role during this process. Here we 
test this hypothesis by blocking the expression of different transcription factors 
using the antisense technique. 
Two inducible transcription factors, which are rapidly expressed in response 
to various extracellular stimuli, are c-Jun and JunB (reviewed by Schlingensiepen 
et al., 1994). Together with JunD they form a protein family that shares 
high-sequence homology in several functionally important domains (reviewed by 
Vogt and Bos, 1990).' Both c-jun and junB belong to the "classical" immediate 
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early genes (lEGs), the most rapidly inducible genes in the cell, which show a 
large and transient increase after stimulation of cells with various stimuli 
(reviewed by Sheng and Greenberg, 1990; Morgan and Curran, 1991). The junD 
gene, in contrast, is not an lEG but is constitutively expressed in considerable 
amounts in many cell types and tissues. However, like the other two family 
members, JunD is a transcription factor that binds specific DNA elements and 
thus regulates transcription of the respective target genes. All three Jun proteins 
form either homodimers or heterodimers with other leucine zipper-type proteins, 
including members of the Fos family. 
The transactivation properties and binding affinities of the three Jun proteins 
differ from each other (SchUtte et al., 1989; Chiu et al., 1989; Ryseck and Bravo, 
1991). However, until recently, little was known about the function, e.g., of JunB 
and JunD in cell proliferation and of all three Jun transcription factors in cell 
differentiation. Moreover, hardly anything is known about their role in complex 
processes such as plastic adaptations in th brain, albeit their expression during 
these processes was frequently shown. 
The c-jun gene is a protooncogene that promotes cell growth. In contrast, 
experiments with antisense oligonucleotides recently showed that junB and junD 
are inhibitors of cell proliferation (Schlingensiepen and Brysch, 1992). The 
inhibition of cell growth by junD was recently confirmed by overexpression 
experiments (Pfarr et al., 1994). JunB not only is a negative regulator of 
proliferation, but also plays an important role in cell differentiation. JunB 
expression is required both for commitment to differentiation of PC-12 pheoch-
romocytoma cells (Schlingensiepen et al., 1993) and for differentiation of 
hippocampal neurons in the post commitment stage (Schlingensiepen eta/., 1994). 
The c-Jun protein, in contrast is a counterplayer with respect to these functions. 
Since the findings of a growth inhibitory role of JunB and JunD were 
obtained in cell lines, they need to be confirmed in primary cultures of 
proliferating cells. Here we analyze the role of the three Jun proteins in the 
proliferation of primary cultures of human fibroblasts. 
Because of the essential role of JunB in cell differentiation, we studied 
possible posttranslational modifications of the JunB transcription factor during 
cell differentiation. We found specific phosphorylation of the JunB protein during 
nerve growth factor (NGF)-induced differentiation of PC-12 cells. 
In vivo, JunB and c-Fos are the predominantly expressed AP-1 transcription 
factor components in the suprachiasmatic nucleus (SCN) of rat brain after light 
stimulation that induces resetting of the circadian clock (Kornhauser et al., 1992). 
Such a phase shift of the circadian rhythm can be induced in rats housed in 
darkness by a light pulse during the subjective night phase (reviewed by Wollnik, 
1992). To determine the functional relevance of the JunB/c-Fos coexpression in 
this paradigm, we interferred with their expression using the antisense technique. 
Cosuppression of the c-Fos and JunB transcription factors in rat SCN with 
antisense oligonucleotides completely prevented the light-induced phase shift of 
the circadian rhythm, while injection of randomized control oligonucleotide had 
no effect. 
The inducible transcription factors c-Jun and JunB are antagonists not only 
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with respect to their role in cell differentiation and proliferation, but also with 
respect to neuronal cell death and survival. Following inhibition of JunB 
expression with antisense S-ODN in cultured rat hippocampal neurons, we found 
a reduction in neuronal survival by two-thirds. In contrast, hippocampal neurons 
treated with anti-c-jun oligonucleotide displayed strongly increased survival 
compared to untreated and control oligonucleotide treated neurons. 
Taken together, these findings show that the Jun transcription factors play a 
fundamental role in such diverse processes as cell proliferation, cell 
differentiation, programmed cell death, and neuronal plasticity. 
MATERIALS AND METHODS 
Antisense Phosphorothioate Oligodeoxynucleotide (S-ODN) Synthesis 
S-ODN were synthesized and highly purified as described previously (Schlin-
gensiepen et a/., 1993; Brysch et al., 1994). Briefly, oligonucleotides were 
synthesized on an Applied Biosystems Model 394 DNA synthesizer using 
,8-cyanoethyl phosphoramidite chemistry and a 30-min sulfurization step with 
0.5 g elemental sulfur/4.8 ml CS2/4.8 ml pyridine/0.4 ml triethylamine. The se-
quences of c-jun, junB, c-fos, p53, and randomized control oligonucleotides were 
as described previously (Schlingensiepen et al., 1993; Brysch et al., 1994; Gillardon 
et a/., 1994). The junD antisense sequences were TTCGCGTAGACAGG for 
human junD and TCCTCGCCATAGAA for rat junD. Oligodeoxynucleotides 
were purified by reverse-phase HPLC on a Waters Delta-Pak C18 column and 
detritylated with 80% acetic acid. Subsequently, S-ODN were extracted with 
diethyl ether, lyophilized, and resuspended in water. Finally, S-ODN were 
purified by anion-exchange chromatography on a Waters Protein-Pak DEAE 
8HR column as follows: gradient-10-100? B, linear over 45 min, hold for 10 min; 
buffer A-25 mM Tris/C1, 1 mM EDTA, pH 8.0, 10% acetonitrile; buffer 
B-2.5 M NaCl in A. S-ODN eluted around 90% of buffer B. S-ODN were 
precipitated from the eluate with 2 X val 100% EtOH, resuspended in sterile 
water and dialyzed against 0.1 M Tris, pH 8.0. 
Fluorescein isothiocyanate (FITC) labeling was performed using a C3-amino-
linker (Glen Research). For the labeling reaction, 100 nmol of 5' C3-amino-
modified oligonucleotide was diluted in 400 JLl of 1 M carbonate-bicarbonate 
buffer (pH 9), to which 5 mg of fluorescein isothiocyanate was added, dissolved in 
400 JLl of 50% dimethylformamide. The labeling reaction was carried out at 37°C 
for 2 hr in the dark. Labelled oligonucleotides were separated from unincorpor-
ated product by reverse-phase HPLC on a C18 column and the product peak was 
lyophilized and purified as described previously (Tischmeyer et al., 1994). 
Cell Proliferation Experiments 
Primary human skin fibroblasts were established and grown for five passages 
in RPM! medium (GIBCO) supplemented with 10% fetal calf serum (FCS). For 
thymidine incorporation experiments, cells were then plated into 96 well 
fiat-bottom microplates at a density of 2500 cells/well in RPM! medium with 5% 
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FCS. S-ODN were added at a 2 p.M concentration 1 hr after plating. Before 
harvesting, cells were incubated with 0.15 p.Ci 3H-thymidine per well for 6 hr. 
Cells were lysed by freezing, spotted onto glass filters, and washed and the 
amount of incorporated tritium was determined by liquid scintillation counting. 
PC-U Cell Differentiation 
PC-12 pheochromocytoma cells were plated into poly-L-lysine-coated 96-well 
fiat-bottom microplates at a density of 2500 cells/well in Dulbecco's modified 
Eagle's medum (DMEM), supplemented with 5% FCS. S-ODN were added at a 
2 p.M concentration 6 hr after plating. Twenty-four-hours after plating cells were 
incubated with 10 ng/ml NGF (Sigma) for 10 days. Neuronal differentiation was 
assessed independently by two different observers in a blinded fashion. 
Primary Rat Hippocampal Cultures 
Hippocampi from the brains of embryonal day 18/19 rats were dissociated by 
mild trypsinization and plated into 96-well plates at a density of 6.4 x lOS /ml in a 
serum free mixture of HM medium (Honegger) and N2 medium (Boddenstein-
Sato) (1: 1, v: v), conditioned by primary rat astrocytes. Oligonucleotides were 
added 4 hr after plating at a concentration of 1 p.M. Neuronal survival . was 
assayed using the fluorescein diacetate/ ethidium bromide double-staining method 
as described previously (Schlingensiepen et al., 1994). For oligonucleotide uptake 
studies FITC-labeled S-ODN were added to the culture medium at a 1 p.M 
concentration 4 days after plating of neurons. 
Western Blotting 
PC-12 cells were plated into poly-L-lysine-coated 260 ml culture flasks at a 
density of 4 x 106 cells in 30 ml of DMEM, supplemented with 5% FCS. After 
24 hr, cells were serum starved for 24 hr by incubation in DMEM with 1% FCS. 
On the next day, either cells were stimulated with 40 ng/ml NGF to induce 
neuronal-like differentiation or they were stimulated to proliferate by the addition 
of 10% FCS to the culture flask. At the time points 4, 8, 24, 48, and 72 hr after 
treatment with NGF or FCS, cells were harvested and processed for western 
blotting. 
At the time points indicated cells were lysed by the addition of lysis buffer 
consisting of 0.1 M Tris buffer (pH 6.8), 20% glycerin, 2% sodium dodecyl sulfate 
(SDS). For dephosphorylation experiments, lysates were incubated with bovine 
intestinal alkaline phosphatase type XXX-L (Sigma) at 0.3 U/ p.g lysate for 30 min 
at 37°C. Proteins were separated by electrophoresis on a 10% SDS-
polyacrylamide gel (SDS-PAGE) and blotted onto Immobilon-P membrane 
(Millipore). Blots were probed with either rabbit polyclonal anti-c-Jun antibody 
(Oncogene Science, PC 07), rabbit polyclonal anti-JunB antibody (Santa Cruz, 
N-17), or a second rabbit polyclonal anti-JunB antibody (Santa Cruz, N-210). The 
two anti-JunB antibodies are directed against different epitopes of the JunB 
protein. For antibody detection, goat anti-rabbit IgG-alkaline phosphatase 
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conjugate (Boehringer Mannheim) was used as the second antibody. Detection 
was performed by chemiluminescence with CSPD (Tropix) according to 
manufacturer's instructions. 
Antisense Experiments in Vivo 
Anesthetized adult male rats (100 mg/kg ketamine hydrochloride and 10 mg 
xylazine) were implanted stereotaxically with a microinjection guide cannula, 
targeted to the bottom of the third ventricle at the level of the ventral SCN. Two 
weeks later, the animals were placed in cages equipped with a running wheel, 
connected to an online monitoring computer system as described previously 
(Wollnik, 1991). Rats were housed under continuous darkness for 16 weeks. 
Every 4 weeks rats were exposed to a light pulse (300 lux for 1 hr) at 
subjective circadian time 15 hr (CT 15). At this time point of the circadian cycle, 
light pulses induce maximal phase shift of circadian activity rhythms. Randomized 
control S-ODN (1 mM in 4 J.tl) or a mixture of anti-c-fos and anti-junB S-ODN 
(1 mM in 2 J.tl each), diluted in physiological saline, was injected 6 hr prior to light 
exposure. 
Phase shifts in circadian rhythmic activity were determined according to 
Daan and Pittendrigh (1976). Differences between experimental groups were 
analyzed by univariate one-way analysis of variance (Statistica, StatSoft, Tulsa, 
OK). Sheffe's multiple t test was used for individual mean comparisons. 
Immunohistochemistry 
To determine protein suppression in rat SCN after treatment with either 
antisense or control oligonucleotides, a subset of animals was sacrificed 4 hr after 
light exposure. Following transcardial perfusion with 4% paraformaldehyde under 
anesthesia, brains were removed, cryoprotected in 30% sucrose, and sectioned on 
a cryostat (35 J.tm). Free-floating sections were processed for immunocyto-
chemistry. Primary antisera (Kovary and Bravo, 1991) were diluted 1:30.000 for 
c-Jun and 1:4.000 for JunB. Detection was performed as previously described 
using the avidin-biotin protocol (Herdegen et al., 1991). 
RESULTS 
Proliferation of Human Fibroblasts 
After 24 hr of S-ODN treatment, there was no significant difference in 
thymidine incorporation between untreated cells and those treated with ran-
domized control S-ODN. Treatment with anti-JunB S-ODN as well as with 
anti-JunD S-ODN, however, strongly increased thymidine uptake to more than 
threefold. These values are similar to those obtained after suppression of the 
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Fig. 1. Proliferation of primary human fibroblasts after 
inhibition of JunB, c-Jun, or JunO expression. 3H-
Thymidine incorporation rates in human fibroblasts after 
treatment with 2 p.M concentrations of either control 
S-OON, anti-junB S-OON, anti-c-jun S-OON, anti-junD 
S-OON, or anti-p53 S-OON. Light gray bars: Control cells 
without S-OON addition. Dark gray bars: Cells treated 
with randomized control S-OON. Cross-hatched bars: 
Treatment with anti-junD S-OON. Black bars: Treatment 
with anti-junB S-OON. White bars: Treatment with anti-c-
jun S-OON. Dotted bars: Treatment with anti-p53 S-OON. 
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known growth inhibitory tumor suppressor protein p53 (Fig. 1). In contrast, 
inhibition of c-Jun expression reduced thymidine incorporation by more than 
50%. At 72 hr after a single addition of S-ODNs, proliferation was still increased 
by 50% in anti-JunB-treated cells and to more than threefold in anti-JunD-
treated cells. 
PC-12 CeU Differentiation 
While the effects of JunB and JunD suppression were similar with respect to 
cell proliferation, they were different in PC-12 cell differentiation. Inhibition of 
JunB completely prevented neurite outgrowth and led to increased cell prolifera-
tion. In contrast, suppression of c-Jun protein enhanced morphological 
differentiation, while suppression of JunD protein did not alter the morphological 
differentiation pattern. Similarly, p53 antisense S-ODN-treated cells did not 
significantly differ from control cells with respect to neurite outgrowth (Fig. 2). 
Thus, suppression of the rapidly inducible transcription factors c-Jun and JunB 
showed opposing functions in cell differentiation. But suppression of neither the 
more constitutively expressed JunD transcription factor nor the p53 tumor 
suppressor protein altered morphological differentiation of neuronal 
differentiation of PC-12 cells. 
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Fig. 2. Differentiation of PC-12 cells after inhibition of JunB, c-Jun, JunO, or p53 
expression. Morphological differentiation of PC-12 cells after treatment with 2 P-M 
concentrations of different S-ODN. (A) Untreated control cells. (B) Treatment with 
randomized control S-ODN. (C) Cells treated with anti-c-jun S-ODN. (D) Cells treated with 
anti-junB S-ODN. (E) Treatment with anti-junD S-ODN. (F) Treatment with anti-p53 
S-OON. Morphological differentiation. of PC-12 cells was completely prevented by anti-junB 
S-ODN. In contrast, enhancement of neurite outgrowth was seen after treatment with 
anti-c-jun S-ODN. Inhibition of expression of the two proteins JunD and p53 did not show 
significant differences from control conditions. 
JunB Phosphorylation During PC-12 Cell Differentiation 
The dependence of PC-12 cell differentiation on JunB expression, as revealed 
by the antisense experiments, prompted us to determine whether posttransla-
tional modifications of JunB might also be involved in the differentiation process. 
Four hours after treatment of serum-starved PC-12 cells with either NGF or FCS, 
western blotting revealed no difference in JunB expression. However, after 8 hr 
J unB expression had· almost disappeared in FCS treated cells, while it was still 
Role of Jun Proteins in Reprogramming of Cell Function 495 
4h 8h 24h 48h 72h 
iif' .. ' - .- . 
• • 
-=- " ~._ ....... ~ 
FCS NGF FCS NGF FCS NGF FCS NGF FCS NGF 
Fig. 3. Expression of a high molecular weight form of JunB in differentiating PC-12 cells. Western 
blot of PC-12 cell lysates after induction of differentiation with NGF or of proliferation with FCS, 
probed with an anti-JunB antibody. JunB expression was induced by both stimuli (lower arrow). At 8 
and 24 hr after stimulation, JunB expression is more intense in NGF-treated cells, compared to FCS 
stimulation. Beginning at 24 hr after stimulation, a second higher molecular weight band begins to 
appear in NGF·treated cells (upper arrow). After 72 hr following NGF treatment, almost all of the 
protein detected by the anti-JunB antibody is present in the high molecular weight form. 
present-albeit at a lower level-in NGF-treated cells. After 24 hr not only was 
expression of JunB more pronounced in NGF-treated cells, but also, a second, 
higher molecular weight band-only faintly observed at the early time points-
became clearly visible. After 48 hr of NGF stimulation about half of the JunB 
protein was already present in this high molecular weight form. In contrast, this 
band was almost undetectable in FCS-treated cells. At 72 hr after NGF addition 
nearly all the JunB protein was present in the high molecular weight form (Fig. 
3). In contrast, western blots probed with an anti-c-Jun antibody revealed no 
increase in the apparent molecular weight of c-Jun after NGF stimulation. To 
determine whether the higher molecular weight form of JunB in differentiating 
PC-12 cells was the result of phosphorylation, an aliquot of the cell lysates was 
treated with alkaline phosphatase. Phosphatase treatment led to complete 
disappearance of the high molecular weight band in NGF treated cells, while the 
low molecular weight band reappeared (Data not shown). To confirm further that 
the upper molecular band represents a form of JunB protein, a second anti-JunB 
antibody, raised against a different epitope of JunB, was used. Again, the same 
higher molecular weight band was detected in NGF-treated cells (Fig. 4). In 
summary, induction of PC-12 cell differentiation by NGF leads to phosphoryla-
tion of JunB. In contrast, stimulation of cell proliferation with FCS does not 
induce JunB phosphorylation. 
1 2 
Fig. 4. Direction of phosphorylated JunB with a 
second antibody. Western blot of PC-12 cell lysates 
after induction of differentiation with NGF. The 
blot was probed with a second anti-JunB antibody 
raised against a different epitope of the protein. 
This antibody again detects the phosphorylated 
form of JunB. Lane 1, 24 hr after NGF treatment; 
Lane 2 48 hr after NGF treatment. 
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Selectivity of Gene Suppressionin in Vivo by Anti-;iunB S-ODN 
A 1-hr light pulse at subjective circadian time 15 hr (CT 15) induced a 
distinct immunoreactivity for c-Fos and JunB and, to a lower extent, for c-Jun and 
FosB. Suppression of c-Fos immunoreactivity in the CNS in vivo by the anti-c-fos 
S-ODN that has been shown previously (Gillardon et al., 1994) was confirmed in 
the antisense-injected animals. The number of c-Fos-immunoreactive nuclei was 
reduced by more than 50% and the intensity of staining was markedly reduced in 
the remaining cells (data not shown). similarly, in antisense-treated animals the 
number of JunB-reactive cells was reduced to less than half compared to those 
injected with control S-ODN. Furthermore, the intensity of staining was strongly 
reduced in the remaining cells (Figs. SA and B). In contrast, the number and 
staining intensity of c-Jun-immunoreactive nuclei were not altered by antisense 
treatment (Figs. SC and D). Equally the immunoreactivity of FosB and JunD was 
not changed (data not shown), confirming in vivo the selectivity of JunB 
suppression by the anti-junB S-ODN previously demonstrated in cell culture 
(Schlingensiepen et al .. 1994). 
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Fig. 5. Selectivity of antisense-mediated protein suppression in vivo. Immunohistochemical 
detection of JunB and c-Jun expression in SCN after treatment of rats with a light pulse. (A, B) 
JunB expression; (C, D) c-Jun expression. A and C are from animals not injected with antisense 
oligonucleotide. B and D are from animals injected with a combination of anti-junB and anti-c-fos 
oligonucleotide prior to the light pulse. Note the selective reduction of JunB but not of c-Jun 
expression. 
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Inhibition of Circadian Rhythm Shift by junB and c-fos Cosuppression in the 
Rat 
Rats treated with a 1-hr light pulse at CT 15 displayed a robust phase shift of 
more than 2 hr in circadian rhythmic activity ( -125 ± 15 min). Animals injected 
with nonsense control oligonucleotide prior to the light pulse showed a similar 
phase shift by more than 2 hr ( -127 ± 20 min). In contrast, in animals injected 
with a combination of anti-junB S-ODN and anti-c-fos S-ODN, the phase shift 
was prevented ( -10 min± 16 min) (Fig. 6). To confirm these results in individual 
rats, animals were injected with control S-ODN at one time point and with 
antisense S-ODNs 4 weeks later. Figure 7 shows activity of a control animal, not 
injected with S-ODNs, subjected to a light pulse (LP) on day 36 of the experiment 
and a second time 4 weeks later. Both light pulse treatments result in a phase shift 
of 100 and 130min, respectively. Figure 8 shows the activity record from an 
animal that received antisense oligonucleotides (ASO) the first time and nonsense 
control S-ODN (NSO) 4 weeks later. Antisense S-OON treatment 6 hr before the 
light pulse prevented light-induced circadian phase shift, while the same animal, 
injected with randomized nonsense control S-ODN (NSO) 4 weeks later, showed 
a phase shift of 130 min in circadian rhythmic activity. This finding was confirmed 
in another animal, yielding similar results. Phase shift after control oligo (NSO) 
injection prior to light pulse treatment was 160 min in this animal, while antisense 
treatment again prevented the phase shift (Fig. 9). 
Etfects of Anti-c-jun and Anti-junB S-ODN on Neuronal Survival 
Following treatment with anti-junB S-ODN, neuronal survival was reduced 
to 61% of controls on day 7 and to 27% on day 15. In contrast, in anti 
c-jun-treated cells, neuronal survival was increased by 54% on day 15 compared 
to cells treated with randomized control oligonucleotide and by 51% compared to 
untreated control neurons (Fig. 10). 
The uptake of FITC-labeled S-ODN was very efficient in neurons. Strong 
labeling of neurons was observed after 72 hr of FITC-S-ODN incubation. FITC 
labeling was not confined to neuronal cell bodies, but was also seen in the 
neurites (Fig. 11). To control for possible uptake of FITC that might have 
resulted from degradation of the FITC-S-ODN complex, uncoupled FITC was 
added to neuronal cultures. No significant labeling of neurons was observed in 
these control cells. 
DISCUSSION 
Inhibition of Jun Transcription Factor Expression with Antisense Molecules 
The antisense technology is particularly suited for the analysis of transcrip-
tion factor function. Since these are intracellular proteins, inactivation by 
antibodies is difficult in vitro and impossible in vivo. A further approach, more 
commonly used, is the overexpression of genes to study the physiological 
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Fig. 6. Phase shift in rat activity after light pulse 
treatment. Black bar: Animals treated with light pulse 
alone. White bar: Animals injected with a combina-
tion of anti-junB and anti-c-fos oligonucleotide prior 
to the light pulse. Gray bar: Animals injected with 
randomized control oligonucleotide before light pulse 
treatment. 
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function of the encoded proteins. However, massive overexpression of a 
transcription factor will alter its concentration-dependent DNA binding pro-
perties and enable binding to low-affinity sites. Furthermore, a transcription 
factor may activate a gene at a low concentration and repress it at a high 
concentration (Sauer and Jackie, 1993). 
Whereas generation of transgenic "knowkout" animals is a valuable tool for 
developmental studies, it is often of limited value for functional analysis in the 
adult animal, since it may lead to serve abnormalities during development. Thus, 
the antisense approach offers a valuable alternative to these techniques. Phos-
phorothioate oligodeoxynucleotides (S-ODN) are nuclease resistant and allow the 
selective inhibition of the synthesis of single proteins. The resulting loss of 
function permits conclusions on the natural function of the suppressed proteins 
and/or their role in disease processes in vitro and in vivo (Patinkin et at., 1990; 
Schlingensiepen and Brysch, 1992, Jachimczak et at., 1993; Behl et at., 1993; 
Schlingensiepen et at., 1993; Stein and Cheng, 1993, Lev-Lehmann et at., 1994, 
Tischmeyer et at., 1994). 
In our cell proliferation experiments, inhibition of the three Jun transcription 
factors in primary human fibroblasts revealed very different roles in cell growth. 
Both JunD and JunB proved to be inhibitors of cell proliferation, similar to the 
findings obtained in permanent cell lines (Schlingensiepen and Brysch, 1992; 
Schlingensiepen et at., 1993; Pfarr et at., 1994). This functional antagonism of 
JunB and JunD to the protooncogene c-Jun in cell proliferation is initially 
surprising but may be an important mechanism for fine-tuning of cellular 
responses to extracellular stimuli. 
In vivo, a large number of signal molecules converge on every cell at the 
same time, e.g., growth factors, hormones, differentiation factors, and cytokines. 
All of these signals can induce certain cellular programs like differentiation, 
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Fig. 7. Circadian rhythm shift after light pulse treatment. 
Left: The activity of an individual rat as measured by online 
monitoring. Each bar represents 20 min of running wheel 
activity. Right: The same activity plot, with a dotted line 
connecting the beginning of activity according to Daan and 
Pittendrigh (1976). Also, on the right the times of light pulse 
treatment as indicated (LP). 
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changes in cell structure, cell proliferation, or programmed cell death ( apoptosis ), 
to name just a few. Most of these signals induce one or several of the Jun 
proteins, often in combination with other transcription factors. The fact that the 
different Jun proteins can act in an opposing manner but are often coexpressed 
suggests that their relative amounts may play a significant role in determining 
which of the above mentioned cellular programs will actually be activated (Gass 
et al., 1993). 
This would require varying intensity of relative expression of the different jun 
genes in changing physiological situations. Indeed, alterations in the time course 
and magnitude of jun gene expression are observed during organ development. 
c-jun expression predominates during the proliferation phase, while junB 
expression is predominant during the differentiation stage (Dungy et aL, 1991; 
Wilkinson et aL, 1989). This expression pattern fits well with the functional 
analysis in our PC-12 cell differentiation experiments, showing that c-Jun inhibits 
and JunB promotes differentiation of PC-12 cells. Initially both jun genes are 
coexpressed after stimulation ·with NGF (Schlingensiepen et aL, 1993). This 
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Fig. 8. Difference in phase shift after specific or nonsense 
S-OON injection. Activity plot from a rat injected with a mix 
of anti-junB and anti-c-fos antisense oligonucleotides (ASO) 
prior to light pulse (LP) treatment on day 36. No phase shift 
is induced. In contrast, injection with control nonsense 
oligonucleotide (NSO) on day 64 prior to the 1 hr light pulse 
does not prevent the phase shift: The phase shift is 130 min. 
coincides with a transient stimulation of cell growth. The phase of morphological 
differentiation correlates with the time, when c-jun mRNA expression has 
decreased, while junB mRNA is still expressed at high levels. Interestingly, 
inhibition of the less regulated JunO protein does not show a measurable effect 
on morphological differentiation 1n the antisense experiments. Possibly JunD 
expression plays a role for the fine tuning of other processes in the CNS, e.g., 
nerve regeneration after injury (Herdegen et al., 1993). 
Phosphorylation of JunB in CeO Differentiation 
Apart from alteration in expression levels, posttranslational modifications 
offer another mechanism for functional modulation of cell programs via transcrip-
tion factors. Thus, Ha-Ras overexpression augments c-Jun activity by stimulating 
phosphorylation of its transactivation domain. This phosphorylation of c-Jun is in 
fact required for the cooperation of c-Jun and Ha-Ras in oncogenic cell 
transformation (Binettuy et al., 1991; Smeal et al., 1991). 
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Fig. 9. Differences in phase shift in a rat with low basic 
activity. Activity plot from a rat with lower basic activity 
compared to that in Fig. 8. Injection with antisense oligonuc-
leotides (ASO) again prevents circadian rhythm phase shift 
after a light pulse (LP). Injection with control nonsense 
oligonucleotide (NSO) leads to a normal phase shift of 
160min. 
Fig. 10. c-jun antisense oligo prevents neuronal cell 
death. Survival of developing hippocampal neurons 
after treatment with different antisense oligonuc-
leotides. Anti-c-jun oligonucleotide strongly increases 
neuronal survival by more than 50% by day 15 and 
inhibits the cell death occurring under both control 
conditions. Values are expressed as a percentage of 
the untreated controls. Neurons were incubated with 
the following oligonucleotides: gray bars, control S-
ODN; black bars, anti-junB S-ODN; white bars, 
anti-c-jun S-OON. The dotted line marks the value of 
untreated control neurons, set at 100%. 
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A B 
tig. 11. Neuronal uptake of FITC-labeled S-ODN. Fluorescence labeling of hippocampal neuronal 
cultures after (A) 2 hr of incubation with FITC-labeled S-ODN: (B) 72 hr of FJTC-S-ODN 
incubation. 
Here we provide data that show specific induction of JunB phosphorylation 
in response to induction of cell differentiation. This may suggest that phos-
phorylation of JunB plays an equally important role in cell differentiation. Thus, 
it is conceivable that while c-Jun phosphorylation is required to transmit the 
mitogenic and oncogenic signaling of Ha-Ras, phosphorylation of JunB is 
required to mediate the differentiation signal. Mapping of the phosphorylation 
sites of JunB will be required in the future to determine where they are located, 
e.g., in the activation domain or in. the DNA-binding domain of the JunB protein 
and to allow site specific mutagenesis for further characterization of phosphoryla-
tion effects. 
In any case, the opposite phosphorylation patterns in differentiation and 
proliferation of c-Jun and JunB not only show that they act in an opposing 
functional manner, but also suggest that their activity is regulated by different 
kinases. Thus, not only their expression, but also their posttranslational modifica-
tion is regulated by different intracellular pathways. Phosphorylation of c-Jun is 
part of the proliferation-inducing cascade activated by Ha-Ras overexpression, 
but not of NGF-induced cell differentiation. In contrast, JunB phosphorylation 
occurs in response to differentiation-inducing stimuli, but not after induction of 
proliferation. 
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Taken together, the results of the proliferation experiments and the results 
on JunB phosphorylation during differentiation may suggest that expression of 
unphosphorylated J unB is sufficient to inhibit cell growth, while phosphorylation 
of JunB is required for the actual differentiation process. 
Cosuppression of JunB and c·Fos in Vivo 
The functional significance of transcription factor induction in the brain is an 
area of intense research that is only just emerging. Models of neuronal plasticity 
have to be combined with functional analysis of transcription factor action. 
Resetting of the circadian rhythm offers a well-defined model of neuronal 
plasticity, in which a circumscribed structure, the suprachiasmatic nucleus (SCN), 
is the predominant pacemaker (reviewed by Takahashi, 1993). Light-induced 
phase shifts are correlated with immediate early gene (lEG) expression, including 
junB, c-jun, fosB, and c-fos. The c-Fos and JunB transcription factors exert the 
main inducible transcription activity of AP-1 proteins in vivo following light pulse 
stimulation (Kornhauser et al., 1992). Their induction in the SCN by light occurs 
only during that circadian time, when light is capable of shifting the circadian 
rhythm and occurs mainly in the ventrolateral part, which received input from 
retinal afferents (reviewed by Takahashi, 1993). Our antisense experiments 
demonstrate that this correlation of JunB and c-Fos expression with circadian 
rhythm shift is of causal relevance. 
Long-term alterations in circadian rhythmic activity are prevented by 
cosuppression of JunB and c-Fos. This confirms the hypothesis that reprogram-
ming of cellular function in a complex model of neuronal plasticity is dependent 
on the expression of inducible Jun and Fos transcription factors. 
Finally, the opposite role of JunB and c-Jun in neuronal survival and cell 
death in hippocampal cultures suggests that both survival and death of these 
neurons can be regulated by Jun transcription factor expression. The increase in 
survival in anti c-jun-treated neurons becomes apparent after day 7 in culture, the 
time of intense formation of synaptic contacts in hippocampal cultures (Seifert et 
al., 1983). Thus, competition for synaptic contacts may act via the c-Jun 
transcription factor to regulate the number of neurons by programmed cell death. 
The role of c-Jun in cell proliferation and our results on its role in neuronal 
cell death are reminiscent of the bivalent regulatory role of c-myc that can either 
lead to cell proliferation or to apoptosis, depending on the supply with growth 
factors and trophic factors (reviewed by Wyllie, 1993). 
Furthermore, the increase in neuronal survival after treatment of cells with 
antisense c-jun oligonucleotides highlights the therapeutic potential of antisense 
oligonucleotides for treatment of diseases involving programmed neuronal cell 
death, including such prevalent diseases as delayed neuronal cell death after 
hypoxic brain injury and Alzheimer type neuronal degeneration. 
In conclusion, the expression of inducible transcription factors is essential for 
the realization of alterations in cell function and structure as required by changing 
physiological demands. Thus, their suppression with selective antisense oligonuc-
leotides allows intervention with such vital and complex processes as 
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programmed neuronal cell death and resetting of the circadian pacemaker which 
represents a specific form of a memory engram. 
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